Catalyst Wire Dossier Catalyst Wire Dossier

DITPA (3,5-diiodothyropropionic acid)

3,5-diiodothyropropionic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DITPA (3,5-diiodothyropropionic acid), covering 2013-04-02 to 2013-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients [Phase 1, Phase 2]

See pricing